Both testosterone injections and cream can raise testosterone under a prescriber's care. We run a 55+ biomarker panel, have a physician review the results, and retest to see what changed with treatment.
Topical gel carries an FDA boxed warning about secondary exposure, including reported virilization in children who came into contact with treated skin.1 Among testosterone formulations, short-acting injections have the highest associated incidence of erythrocytosis.2
Neither route exactly reproduces the body's daily testosterone rhythm. Before prescribing either form, your physician weighs your labs, household exposure, tolerability, and monitoring.3
Testosterone Injections vs Cream at a Glance
The two routes differ most in household exposure, erythrocytosis risk, and peak-to-trough patterns. Those differences affect how your physician monitors treatment and how the prescription fits into your daily life.
| Route | Formulation basis from the label | Boxed warning or route-specific risk | Relative erythrocytosis risk | Peak and trough pattern |
|---|---|---|---|---|
| Injectable testosterone cypionate | Testosterone cypionate in an oil-based solution containing cottonseed oil, benzyl benzoate, and benzyl alcohol.4 | It does not carry the gel warning for secondary skin exposure. Injection-site reactions are a separate tolerability issue.4 | Short-acting injectable formulations have the highest associated incidence among testosterone formulations reviewed.2 | Depot release produces route-specific peaks and troughs. The pattern does not reproduce normal daily testosterone secretion.3 |
| Topical testosterone gel | Testosterone delivered through a topical gel placed on the skin.1 | The boxed warning covers secondary exposure and reported virilization in exposed children.1 Skin irritation can also affect tolerability. | Erythrocytosis can occur with testosterone therapy, although the review places short-acting injections above other formulations.2 | Topical exposure can track intraday variation more closely than depot release. It still does not duplicate natural secretion exactly.3 |
Neither column supports a universal winner. The injection route avoids skin transference, while topical gel avoids injection-site reactions and the higher erythrocytosis association reported with short-acting injectable formulations.
Your health history can change how much weight each difference receives. Your prescriber also needs follow-up labs because tolerability alone cannot show whether testosterone or red blood cell measures have moved outside the intended range.1,4
What Cream Means in This Comparison
The topical comparator is testosterone gel because the cited federal label is for AndroGel. The label describes testosterone delivered through a gel placed on the skin.1
People often use “cream” as a broad term for topical testosterone. A compounded cream may have a different base, concentration, and application instructions. The AndroGel label should not be treated as the label for every compounded product.
That distinction affects your consultation. Ask your prescriber to identify the exact topical formulation being considered and explain which label or pharmacy instructions apply to it. The medication name matters more than the shorthand used in a search or online discussion.
Injectable testosterone cypionate is also a specific formulation. The DEPO-TESTOSTERONE label from Pharmacia & Upjohn describes testosterone cypionate in cottonseed oil with benzyl benzoate and benzyl alcohol.4 It is an injectable depot formulation and is not intended for intravenous use.4
Cypionate is only one injectable ester. The differences among cypionate, enanthate, and propionate belong in an ester-specific testosterone comparison.
Secondary Exposure With Topical Testosterone
Topical testosterone creates a third-party exposure risk because medication can remain on treated skin. The AndroGel boxed warning states:
> “WARNING: SECONDARY EXPOSURE TO TESTOSTERONE. Virilization has been reported in children who were secondarily exposed to testosterone gel... Children should avoid contact with unwashed or unclothed application sites in men using testosterone gel... Healthcare providers should advise patients to strictly adhere to recommended instructions for use.”1
Virilization means developing androgen-related physical changes after testosterone exposure. The warning concerns people who were never prescribed the medication, especially children who come into contact with treated skin.
This is a defined household risk. It does not establish that gel is more dangerous to the person receiving treatment. It means your prescriber needs to understand who lives with you and whether close skin contact could make transference difficult to control.
If you live with young children, share close caregiving duties, or expect frequent skin contact with another person, raise that during the prescribing visit. Your physician can weigh the labeled exposure warning alongside your labs and treatment goals. Do not switch formulations without that review.
Injectable testosterone does not create this skin-transference pathway. It carries its own route-specific concerns, including injection-site reactions and the higher erythrocytosis association seen with short-acting injectable formulations.2,4
Erythrocytosis Risk With Injections
Erythrocytosis is an increase in red blood cell concentration during testosterone therapy. It may appear through changes in hemoglobin or hematocrit on follow-up blood work.
A literature review by Ohlander, Varghese, and Pastuszak found that short-acting injectable testosterone formulations had the highest associated incidence of erythrocytosis among the formulations reviewed.2 The authors also noted that increased blood viscosity can raise concern about coronary, cerebrovascular, and peripheral vascular complications.2
This evidence supports closer attention to blood counts with injectable therapy. It does not prove that every person using injections will develop erythrocytosis. It also does not establish zero risk with topical gel.
Your baseline result gives your physician a starting point. Follow-up measurements show whether your red blood cell markers changed after treatment began. One isolated result provides limited context, while a trend can show whether the prescribing plan needs reassessment.
If your hematocrit is rising during testosterone therapy, management belongs with your clinician. The separate guide to hematocrit management during TRT covers that issue without turning this route comparison into a self-treatment plan.
Peak and Trough Patterns in Testosterone Injections vs Cream
Testosterone concentration patterns vary by route because injectable depots and topical absorption release medication differently. The size, timing, and duration of peaks and troughs can change with the formulation.3
The pharmacokinetic review by Pastuszak and colleagues found that some testosterone therapies produce intraday variation resembling natural circadian secretion. Other formulations create flatter depot-release exposure or concentration changes that exceed the frequency or range of natural variation.3
No testosterone therapy in the review exactly reproduced the daily pattern found in younger men.3 That limits claims that one route is more natural across every hour of the day.
The review was based on published pharmacokinetic profiles and prescribing information rather than a single head-to-head trial. Three authors were employees of Antares Pharma, a testosterone-therapy manufacturer.3 The disclosure does not erase the findings, but it belongs beside them.
A peak-and-trough curve also cannot decide the prescription by itself. Your physician reads concentration patterns alongside your symptoms, baseline labs, follow-up results, and adverse effects. A smoother curve has limited value if the route creates an unworkable household exposure problem or persistent skin irritation.
Factors in the Prescribing Decision
A prescriber weighs the route-specific risks against your health history and daily circumstances. The discussion usually includes several practical areas.
- Monitoring burden. Both routes require periodic clinical review and laboratory testing.1,4 Your physician uses those results to assess testosterone exposure and changes in red blood cell measures.
- Local tolerability. Injections can cause reactions at the injection site, while topical products can irritate the skin.1,4 Tell your physician about persistent local reactions because discomfort can affect whether treatment remains workable.
- Household exposure. Topical gel requires attention to contact with treated skin because of the boxed warning.1 Your living situation may change how your prescriber weighs that risk.
- Concentration pattern. Injectable depots and topical products create different peaks and troughs.3 Follow-up testing helps your physician determine how the selected formulation is behaving in your body.
- Total cost. Medication, laboratory testing, pharmacy charges, and clinical monitoring can move separately. The detailed TRT cost guide explains those line items without reducing the comparison to one advertised monthly price.
A route that looks convenient at the start may require reassessment if your labs move in the wrong direction. The discussion can also change if skin exposure becomes difficult to control or one formulation causes persistent local reactions. Those changes call for a prescriber review rather than an unsupervised switch.
Pellets are another testosterone delivery route, but they involve different procedures and pharmacokinetics. They are outside this two-route comparison.
If you are still deciding whether testosterone therapy belongs in your care, start with the broader testosterone replacement therapy overview. Diagnosis comes before formulation. Symptoms and baseline labs establish whether a testosterone prescription should be considered at all.
The Opt Take on Delivery Choices
Your choice between injections and cream starts after a physician interprets your lab pattern alongside your symptoms, routines, preferences, and treatment goals. A single testosterone result cannot determine the right delivery method for you. The decision should reflect how each option fits your life and how your broader biomarker pattern responds.
You do not receive a standard testosterone kit at Opt Health. Your physician builds an individualized plan, then follows your symptoms, labs, and practical concerns such as application, exposure, and dosing consistency. If the data or your experience points elsewhere, the plan changes. The process is test, understand, treat, retest, and adjust.
Get started: Begin with Opt Health, where a physician reads your labs, builds your plan, and adjusts it over the loop.
Frequently Asked Questions
Testosterone injections are not universally more effective than topical gel. Multiple prescribed routes can reach target testosterone levels when the formulation and monitoring plan are set by a clinician.1,3,4
The routes produce different concentration patterns. Injectable depot formulations create peaks and troughs that differ from topical exposure, while some topical options can follow intraday variation more closely.3 Neither pattern exactly reproduces normal daily secretion.
Your follow-up labs provide the useful comparison. They show whether the prescribed route reaches its intended range and whether blood counts or adverse effects are changing.
Testosterone injections carry a higher associated incidence of erythrocytosis when short-acting injectable formulations are compared with other testosterone formulations.2 Injection-site reactions can also affect tolerability.4
Injections avoid the secondary skin-exposure warning attached to topical gel. That removes one household concern, but it does not make injections safer in every respect.
Your physician should review blood counts and testosterone levels over time. If your results change, the prescribing plan may need adjustment under clinical direction.
No single testosterone formulation is most effective for every person. The pharmacokinetic evidence describes different peak, trough, and intraday patterns rather than a simple ranking.3
Your physician also considers whether the route reaches the intended testosterone range without creating an unacceptable adverse effect. Household exposure, skin reactions, injection tolerance, and erythrocytosis risk can each change the clinical decision.
The exact product matters. Testosterone cypionate injection and testosterone gel have different labels, formulations, and warnings, even though both deliver testosterone.1,4
No prescribed testosterone route works immediately in the sense implied by this question. Each formulation has an absorption and release pattern that develops over time, and the timing differs between topical exposure and injectable depot release.3
A fast peak does not establish better symptom control or a better long-term fit. Your prescriber needs follow-up measurements to assess the response and identify adverse changes.
Bring your baseline and follow-up lab results, household exposure concerns, and tolerability questions to your prescriber when discussing testosterone injections vs cream.
References
- Ascend Therapeutics U.S., LLC. ANDROGEL (testosterone) gel. DailyMed. Accessed September 6, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4e8d29b-8707-4d47-e053-2a95a90aecee
- Ohlander SJ, Varghese B, Pastuszak AW. Erythrocytosis following testosterone therapy. Sex Med Rev. 2018;6(1):77-85. https://pubmed.ncbi.nlm.nih.gov/28526632/
- Pastuszak AW, Gittelman M, Tursi JP, et al. Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age. Andrology. 2022;10(2):209-222. https://pubmed.ncbi.nlm.nih.gov/34510812/
- Pharmacia & Upjohn. DEPO-TESTOSTERONE (testosterone cypionate) injection, solution. DailyMed. Accessed September 6, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cfbb53d4-b868-4a28-8436-f9112eb01c39
This content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.
Start Today
Your health, your terms. Discover how personalized care can transform not just the way you feel, but how you live.